These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

427 related items for PubMed ID: 16129207

  • 1. Relationship of phosphorus and calcium-phosphorus product with mortality in CKD.
    Menon V, Greene T, Pereira AA, Wang X, Beck GJ, Kusek JW, Collins AJ, Levey AS, Sarnak MJ.
    Am J Kidney Dis; 2005 Sep; 46(3):455-63. PubMed ID: 16129207
    [Abstract] [Full Text] [Related]

  • 2. Relationship between homocysteine and mortality in chronic kidney disease.
    Menon V, Sarnak MJ, Greene T, Wang X, Pereira AA, Beck GJ, Kusek JW, Selhub J, Collins AJ, Levey AS, Shlipak MG.
    Circulation; 2006 Mar 28; 113(12):1572-7. PubMed ID: 16549639
    [Abstract] [Full Text] [Related]

  • 3. Association of disorders in mineral metabolism with progression of chronic kidney disease.
    Schwarz S, Trivedi BK, Kalantar-Zadeh K, Kovesdy CP.
    Clin J Am Soc Nephrol; 2006 Jul 28; 1(4):825-31. PubMed ID: 17699293
    [Abstract] [Full Text] [Related]

  • 4. Body mass index and mortality in CKD.
    Madero M, Sarnak MJ, Wang X, Sceppa CC, Greene T, Beck GJ, Kusek JW, Collins AJ, Levey AS, Menon V.
    Am J Kidney Dis; 2007 Sep 28; 50(3):404-11. PubMed ID: 17720519
    [Abstract] [Full Text] [Related]

  • 5. Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community.
    Dhingra R, Sullivan LM, Fox CS, Wang TJ, D'Agostino RB, Gaziano JM, Vasan RS.
    Arch Intern Med; 2007 May 14; 167(9):879-85. PubMed ID: 17502528
    [Abstract] [Full Text] [Related]

  • 6. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study.
    Go AS, Yang J, Ackerson LM, Lepper K, Robbins S, Massie BM, Shlipak MG.
    Circulation; 2006 Jun 13; 113(23):2713-23. PubMed ID: 16754803
    [Abstract] [Full Text] [Related]

  • 7. Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the Kidney Early Evaluation Program (KEEP).
    Bhuriya R, Li S, Chen SC, McCullough PA, Bakris GL.
    Am J Kidney Dis; 2009 Apr 13; 53(4 Suppl 4):S3-10. PubMed ID: 19285609
    [Abstract] [Full Text] [Related]

  • 8. Chronic kidney disease and risk of incident myocardial infarction and all-cause and cardiovascular disease mortality in middle-aged men and women from the general population.
    Meisinger C, Döring A, Löwel H, KORA Study Group.
    Eur Heart J; 2006 May 13; 27(10):1245-50. PubMed ID: 16611670
    [Abstract] [Full Text] [Related]

  • 9. Serum phosphorus and cardiovascular mortality in type 2 diabetes.
    Chonchol M, Dale R, Schrier RW, Estacio R.
    Am J Med; 2009 Apr 13; 122(4):380-6. PubMed ID: 19332233
    [Abstract] [Full Text] [Related]

  • 10. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS, Bishu K, Rector TS, Ishani A, Kuskowski MA, Cohn JN.
    Circulation; 2009 Oct 20; 120(16):1577-84. PubMed ID: 19805651
    [Abstract] [Full Text] [Related]

  • 11. Relation of baseline presence and severity of renal disease to long-term mortality in persons with known stroke.
    Ani C, Ovbiagele B.
    J Neurol Sci; 2010 Jan 15; 288(1-2):123-8. PubMed ID: 19853862
    [Abstract] [Full Text] [Related]

  • 12. Adiponectin and mortality in patients with chronic kidney disease.
    Menon V, Li L, Wang X, Greene T, Balakrishnan V, Madero M, Pereira AA, Beck GJ, Kusek JW, Collins AJ, Levey AS, Sarnak MJ.
    J Am Soc Nephrol; 2006 Sep 15; 17(9):2599-606. PubMed ID: 16885405
    [Abstract] [Full Text] [Related]

  • 13. Calcium, phosphorus, PTH and death rates in a large sample of dialysis patients from Latin America. The CORES Study.
    Naves-Díaz M, Passlick-Deetjen J, Guinsburg A, Marelli C, Fernández-Martín JL, Rodríguez-Puyol D, Cannata-Andía JB.
    Nephrol Dial Transplant; 2011 Jun 15; 26(6):1938-47. PubMed ID: 20513773
    [Abstract] [Full Text] [Related]

  • 14. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Tentori F, Blayney MJ, Albert JM, Gillespie BW, Kerr PG, Bommer J, Young EW, Akizawa T, Akiba T, Pisoni RL, Robinson BM, Port FK.
    Am J Kidney Dis; 2008 Sep 15; 52(3):519-30. PubMed ID: 18514987
    [Abstract] [Full Text] [Related]

  • 15. Conjoint effects of serum calcium and phosphate on risk of total, cardiovascular, and noncardiovascular mortality in the community.
    Larsson TE, Olauson H, Hagström E, Ingelsson E, Arnlöv J, Lind L, Sundström J.
    Arterioscler Thromb Vasc Biol; 2010 Feb 15; 30(2):333-9. PubMed ID: 19948843
    [Abstract] [Full Text] [Related]

  • 16. Renal dysfunction predicts long-term mortality in patients with lower extremity arterial disease.
    Pasqualini L, Schillaci G, Pirro M, Vaudo G, Siepi D, Innocente S, Ciuffetti G, Mannarino E.
    J Intern Med; 2007 Dec 15; 262(6):668-77. PubMed ID: 17908164
    [Abstract] [Full Text] [Related]

  • 17. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
    Brunekreef B, Beelen R, Hoek G, Schouten L, Bausch-Goldbohm S, Fischer P, Armstrong B, Hughes E, Jerrett M, van den Brandt P.
    Res Rep Health Eff Inst; 2009 Mar 15; (139):5-71; discussion 73-89. PubMed ID: 19554969
    [Abstract] [Full Text] [Related]

  • 18. Serum fetuin a in hemodialysis: a link between derangement of calcium-phosphorus homeostasis and progression of atherosclerosis?
    Pertosa G, Simone S, Ciccone M, Porreca S, Zaza G, Dalfino G, Memoli B, Procino A, Bonomini M, Sirolli V, Castellano G, Gesualdo L, Ktena M, Schena FP, Grandaliano G.
    Am J Kidney Dis; 2009 Mar 15; 53(3):467-74. PubMed ID: 19167798
    [Abstract] [Full Text] [Related]

  • 19. Chronic kidney disease, cardiovascular risk, and response to angiotensin-converting enzyme inhibition after myocardial infarction: the Survival And Ventricular Enlargement (SAVE) study.
    Tokmakova MP, Skali H, Kenchaiah S, Braunwald E, Rouleau JL, Packer M, Chertow GM, Moyé LA, Pfeffer MA, Solomon SD.
    Circulation; 2004 Dec 14; 110(24):3667-73. PubMed ID: 15569840
    [Abstract] [Full Text] [Related]

  • 20. The circulating soluble TRAIL is a negative marker for inflammation inversely associated with the mortality risk in chronic kidney disease patients.
    Liabeuf S, Barreto DV, Barreto FC, Chasseraud M, Brazier M, Choukroun G, Kamel S, Massy ZA.
    Nephrol Dial Transplant; 2010 Aug 14; 25(8):2596-602. PubMed ID: 20190248
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.